The FDA has approved Vykat XR (diazoxide choline) for the treatment of hyperphagia in adults and pediatric patients 4 years ...

Semaglutide improved maximum walking distance in patients with type 2 diabetes and symptomatic peripheral artery disease.

Oral semaglutide demonstrated superior cardiometabolic outcomes relative to placebo and active comparators, including empaglifozin, in T2D.

Daily cocoa extract and multivitamin/multimineral supplementation are not associated with a reduced risk for fracture among older adults.

The Trump administration will lay off 10,000 workers at the US Department of Health and Human Services as part of a major reorganization.

The telehealth company Hims & Hers is adding Zepbound and generic liraglutide to its offering of weight-loss drugs.

Hormone diets have taken off on social media as the latest weight loss trend, but their scientific validity remains questionable.

Hypertension was not an independent risk factor for postoperative complications among patients undergoing surgery for pheochromocytoma.

Intermittent fasting yields modestly greater weight loss than daily caloric restriction among adults with overweight or obesity.

Postmenopausal women with CSA were associated with an increased risk of developing ACPA-negative IA and progressing to RA.

Up to 30% of acute kidney injury (AKI) survivors require dialysis and personalized care after discharge from the hospital.

The FDA has approved Blujepa (gepotidacin) for the treatment of female patients 12 years of age and older weighing at least 40kg with uncomplicated UTI.